May 6, 2021

Hospira recalls one lot each of 0.5% Bupivacaine and 1% Lidocaine because of mislabeling

By: Judy Mathias

Editor's Note

Hospira Inc, a Pfizer company, announced May 4 that it is recalling lot EG6023 of 0.5% Bupivacaine Hydrochloride Injection, USP 30 mL and lot EG8933 of 1% Lidocaine HCL Injection, USP 30 mL because of mislabeling.

A portion of each lot was incorrectly labeled as the other product. The issue was identified by a customer.

Sponsored Message

Use of the impacted products could cause adverse events of moderate to high severity.


Get OR Manager Updates

Sign Up Now
Latest Issue of OR Manager
February 2022
Video Spotlight
Live chat by BoldChat